Accelerating Progress in Pediatric Cancer

NCI is pushing the “bench to bedside” paradigm to bring medical advances into the clinic.
Pediatric cancers are considered rare diseases, which makes them more challenging to study and treat. However, efforts like the Childhood Cancer Data Initiative are helping to further disease biology understanding and open pathways for community collaboration. In light of Childhood Cancer Awareness Month, NCI experts discuss the future of advancements such as precision medicine and immunotherapy.

-
Dr. Nirali Shah Hematologic Malignancies Section Head, Pediatric Oncology NCI
-
Dr. Christine Heske Translational Sarcoma Biology Group Head, Pediatric Oncology NCI
-
AFCEA West: AI is America’s ‘Sputnik Moment,’ Defense Academic Says
NPS president says that ‘warrior scholars’ bridge research and implementable capabilities for national security.
12m listen -
Defending the Cyber Domain in a Time of 'Non-Kinetic' Threats
Northcom's intelligence leader Brig. Gen. Maurizio Calabrese discussed the evolving role of defense intelligence technology.
20m watch -
The Year Ahead: FBI’s 2025 Cybersecurity Priorities
The FBI is increasing awareness of vulnerabilities and employing AI-enabled tools to secure networks from sophisticated cyber threats.
25m listen -
OPM Navigates AI Governance Through People
OPM's Taka Ariga explores AI's role in an efficient federal workforce and operations, focusing on trust, data integrity and storytelling.
19m listen